【科笛-B(02487.HK):CU-40102(外用非那雄胺喷雾剂)获得国家药品监督管理局上市批准】智通财经APP讯,

智通财经
30 Jun
【科笛-B(02487.HK):CU-40102(外用非那雄胺喷雾剂)获得国家药品监督管理局上市批准】智通财经APP讯,科笛-B(02487.HK)发布公告,集团的CU-40102(外用非那雄胺喷雾剂)已获得中国国家药品监督管理局上市批准。CU-40102获批的适应症为治疗雄激素性脱发,其是全球首个亦是唯一一个获批用于雄激素性脱发治疗的外用非那雄胺,也是中国首个且唯一一个获批上市的外用非那雄胺。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10